Sentinel node localization in breast cancer using intradermal dye injection: Results, influencing factors and learning curve

Journal of the Medical Association of Thailand

Volumn 88, Issue 3, 2005, Pages 386-390

  Ratanachaikanont, Teeradej ^a   Karalak, Anant ^a  

^a NATIONAL CANCER INSTITUTE   (Thailand)

Author keywords

Breast cancer; Influencing factors; Intradermal dye; Learning curve; Results; Sentinel node

Indexed keywords

ANTINEOPLASTIC AGENT; ISOSULFAN BLUE;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SURGERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; HUMAN; LEARNING; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OPERATION DURATION; OUTCOMES RESEARCH; PREDICTION; SENTINEL LYMPH NODE BIOPSY; SURGICAL APPROACH; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COLORING AGENTS; FEMALE; HUMANS; INJECTIONS, INTRADERMAL; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

EID: 20344372922     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-9.
2. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997; 226: 271-6.
3. Brady MS, Coit DG Sentinel lymph node evaluation in melanoma. Arch Dermatol 1997; 133: 1014-20.
4. Crowe P, Temple W. Management of the axilla in early breast cancer: is it time to change tack? Aus N Z J Surg 2000; 70: 288-96.
5. Giuliano AE. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 1997; 350: 958.
6. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-8.
7. Flett MM, Going JJ, Stanton PD, Cooke TG. Sentinel node localization in patients with breast cancer. Br J Surg 1998; 85: 991-3.
8. Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997; 3: 336-40.
9. Clark GM, McGuire WL. New biologic prognostic factors in breast cancer. Oncology 1989; 3: 49-54.
10. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997; 349: 1864-7.
11. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S, et al. Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275-83.
12. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EF, Boom RP, et al. Impact of lymphoscintigraphy on sentinel node identification with technitium-99m-colloidal albumin in breast cancer. J Nucl Med 1997; 38: 366-8.
13. Roumen RM, Valkenberg JG, Geuskens LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 1997; 23: 495-502.
14. Galimberti V, Zurrida S, Zucali P, Luini A. Can sentinel node biopsy avoid axillary node dissection in clinically node-negative breast cancer patients? Breast J 1998; 7: 8-10.
15. O'Hea BJ, Hill AD, El-Shirbiny AM, Yeh SD, Rosen PP, Coit DG, et al. Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998; 186: 423-7.
16. Barnwell JM, Arredondo MA, Kollmorgen D, Gibbs JF, Lamonica D, Carson W, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol 1998; 5: 126-30.
17. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 1997; 349: 1668-9.
18. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276: 1818-22.
19. Hill AD, Tran KN, Akhurst, Yeung H, Yeh SD, Rosen PP, T et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999; 229: 528-35.
20. Bergkvist L, Frisell J, Liljegren G, Celebioglu F, Damm S, Thorn M. Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer. Br J Surg 2001; 88: 1644-8.
21. Nason KS, Anderson BO, Byrd DR, Dunnwald LK, Eary JF, Mankoff DA, et al. Increased false negative sentinel node biopsy rates after pre-operative chemotherapy for invasive breast carcinoma. Cancer 2000; 89: 2187-94.
22. Tafra L, Verbanac KM, Lannin DR. Preoperative chemotherapy and sentinel lymphadenectomy for breasr cancer. Am J Surg 2001; 182: 312-5.
23. Haid A, Tausch C, Lang A, Lutz J, Fritzsche H, Peschina W, et al. Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer 2001; 92: 1080-4.
24. Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breasr cancer may reliable represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 2002; 9: 235-42.
25. Julian TB, Patel N, Dusi D, Olson P, Nathan G, Jasnosz K, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 2001; 182: 407-10.
26. Haigh PI, Hansen NM, Qi K, Giuliano AE. Method of biopsy and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Cancer symposium of the Society of Surgical Oncology. Orlando: FL, 1999.
27. Johnson JM, Orr RK, Moline SR. Institutional learning curve for sentinel node biopsy at a community teaching hospital. Am J Surg 2001; 67: 1030-3.
28. Tafra L. The learning curve and sentinel node biopsy. Am J Surg 2001; 182: 347-50.
29. Cox CE, Bass S, Boulware D, Ku NK, Berman C, Reinigen DS. Implementation of a new surgical technology: outcome measures for lymphatic mapping of breast carcinoma. Cancer symposiun of the Society of Surgical Oncology. Orlando: FL, 1999.